Menu
KrASIA
News

JD.com reveals its health subsidiary is valued at USD 7 billion amid Q3 earnings release

Written by Song Jingli Published on 

Share
It booked RMB 134.8 billion (USD 118.9 billion) in net revenue in the third quarter of this year, up 28.7% year-on-year.

China’s e-commerce giant JD.com announced on Friday that it booked RMB 134.8 billion (USD 118.9 billion) in net revenue in the third quarter of this year, up 28.7% year-on-year.

The company posted RMB 612.3 million (USD 85.7 million) in net income, down from the net income of RMB 3 billion in the same period last year.

After releasing these earnings, JD.com disclosed that JD Health, a majority-owned subsidiary of the company, completed its series A preferred share financing in November, with a valuation of approximately USD 7 billion.

The company added that over the past few years, JD Health has built a comprehensive “Internet + healthcare” ecosystem, providing pharmaceutical and healthcare products, internet healthcare, health management, and intelligent healthcare solutions to customers. JD.com added that the company has grown to become China’s largest online pharmacy by revenue.

Share

You might like these

  • News

    Pinduoduo pioneers neighborhood group-buying service in Shanghai

    By 

    Song Jingli

    14 Jan 2021    09:08 AM

KrASIA InsightsKrASIA Insights

  • What should have been a smooth-sailing ride for WhiteHat Jr after getting acquired by edtech giant Byju’s, it turned out to be a rocky one.

    Insights

    Coding, campaign, and controversies: WhiteHat Jr’s journey from highflyer to the eye of storm

    By Moulishree Srivastava

    14 Jan 202109:33 AM

Most PopularMost Popular

See All